Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why do patients fail HIV therapy?

L Waters1, M Nelson

  • 1St Stephen's Centre, Chelsea & Westminster Hospital, London, UK. laura.waters@btinternet.com

International Journal of Clinical Practice
|May 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-sectional survey of sexual health professionals' experiences and perceptions of the 2022 mpox outbreak in the UK.

BMJ open·2024
Same author

Estimated glomerular filtration rate slopes on tenofovir alafenamide.

HIV medicine·2020
Same author

Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG.

HIV medicine·2020
Same author

A molecular understanding of magnesium aluminium silicate - drug, drug - polymer, magnesium aluminium silicate - polymer nanocomposite complex interactions in modulating drug release: Towards zero order release.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2020
Same author

COVID-19 research: an opinion piece.

HIV medicine·2020
Same author

Real time calorimetric characterisation of clay - drug complex dispersions and particles.

International journal of pharmaceutics: X·2019
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Antiretroviral therapy for HIV can fail due to resistance, poor adherence, or toxicity. Optimizing tolerability and adherence is crucial for successful long-term HIV treatment outcomes.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • Antiretroviral therapy (ART) has significantly reduced HIV-related morbidity and mortality.
  • Despite advances, treatment failure remains a challenge for patients with HIV.

Purpose of the Study:

  • To review the primary reasons for antiretroviral therapy failure.
  • To discuss the roles of transmitted resistance, adherence, toxicity, and drug potency.

Main Methods:

  • Literature review of PubMed and Medline databases.
  • Inclusion of recent conference abstracts on antiretroviral toxicity, adherence, failure, and transmitted resistance.

Main Results:

  • First-line ART regimens exhibit similar potency; tolerability and toxicity are key differentiators.

Related Experiment Videos

  • Pharmacogenomics shows promise in predicting and managing drug toxicity.
  • Good patient adherence is consistently identified as the most critical factor for successful therapy.

    • Conclusions:

    • Minimizing toxicity and addressing adherence barriers are essential for successful long-term HIV management.
    • Future strategies should focus on personalized approaches, including pharmacogenomics, to improve treatment outcomes.